MedPath

Celsius Therapeutics, Inc.

Celsius Therapeutics, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2018-01-01
Employees
11
Market Cap
-
Website
http://www.celsiustx.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

First-in-human, Single Ascending Dose Study of CEL383 in Healthy Adult Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2023-06-13
Last Posted Date
2024-02-09
Lead Sponsor
Celsius Therapeutics, Inc.
Target Recruit Count
48
Registration Number
NCT05901883
Locations
🇺🇸

Celerion, Lincoln, Nebraska, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.